BR112022020809A2 - Composições e métodos para entrega terapêutica direcionada ao osso - Google Patents

Composições e métodos para entrega terapêutica direcionada ao osso

Info

Publication number
BR112022020809A2
BR112022020809A2 BR112022020809A BR112022020809A BR112022020809A2 BR 112022020809 A2 BR112022020809 A2 BR 112022020809A2 BR 112022020809 A BR112022020809 A BR 112022020809A BR 112022020809 A BR112022020809 A BR 112022020809A BR 112022020809 A2 BR112022020809 A2 BR 112022020809A2
Authority
BR
Brazil
Prior art keywords
bone
compositions
methods
therapeutic delivery
directed therapeutic
Prior art date
Application number
BR112022020809A
Other languages
English (en)
Inventor
Alvarez Luis
Stewart David
Park Hyeon
Heil Todd
Original Assignee
Theradaptive Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theradaptive Inc filed Critical Theradaptive Inc
Publication of BR112022020809A2 publication Critical patent/BR112022020809A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

COMPOSIÇÕES E MÉTODOS PARA ENTREGA TERAPÊUTICA DIRECIONADA AO OSSO. São fornecidos aqui polipeptídeos compreendendo uma terapêutica direcionada para entrega a um órgão ou tecido e seus usos.
BR112022020809A 2020-04-15 2021-04-14 Composições e métodos para entrega terapêutica direcionada ao osso BR112022020809A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063010639P 2020-04-15 2020-04-15
PCT/US2021/027230 WO2021211683A2 (en) 2020-04-15 2021-04-14 Compositions and methods for targeted therapeutic delivery to bone

Publications (1)

Publication Number Publication Date
BR112022020809A2 true BR112022020809A2 (pt) 2023-02-23

Family

ID=78084414

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022020809A BR112022020809A2 (pt) 2020-04-15 2021-04-14 Composições e métodos para entrega terapêutica direcionada ao osso

Country Status (10)

Country Link
US (1) US20230235002A1 (pt)
EP (1) EP4135750A2 (pt)
JP (1) JP2023525960A (pt)
KR (1) KR20230011289A (pt)
CN (1) CN115916239A (pt)
AU (1) AU2021254751A1 (pt)
BR (1) BR112022020809A2 (pt)
CA (1) CA3180156A1 (pt)
TW (1) TW202203961A (pt)
WO (1) WO2021211683A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
CA3115298A1 (en) 2018-10-12 2020-04-16 Theradaptive, Inc. Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802396B2 (en) * 2005-12-26 2014-08-12 Yantai Zhenghai Bio-Technology Co., Ltd. Activated collagen scaffold materials and their special fused active restoration factors
GB0818255D0 (en) * 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans
WO2012078671A2 (en) * 2010-12-06 2012-06-14 Massachusetts Institute Of Technology Tricalcium phosphate binding peptides and use thereof
CA3115298A1 (en) * 2018-10-12 2020-04-16 Theradaptive, Inc. Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

Also Published As

Publication number Publication date
EP4135750A2 (en) 2023-02-22
WO2021211683A2 (en) 2021-10-21
CA3180156A1 (en) 2021-10-21
CN115916239A (zh) 2023-04-04
WO2021211683A3 (en) 2021-11-18
TW202203961A (zh) 2022-02-01
KR20230011289A (ko) 2023-01-20
JP2023525960A (ja) 2023-06-20
US20230235002A1 (en) 2023-07-27
AU2021254751A1 (en) 2022-11-17

Similar Documents

Publication Publication Date Title
BR112022020809A2 (pt) Composições e métodos para entrega terapêutica direcionada ao osso
BR112018004536A2 (pt) peptídeos de endereçamento à cartilagem
AR110419A1 (es) Profármacos de principios activos citotóxicos con grupos enzimáticamente escindibles
BR112017007765A2 (pt) composições de adenosina deaminase-2 (ada2), variantes do mesmo e métodos de usar o mesmo
CY1116511T1 (el) Μεθοδος αγωγης του κολπικου ινιδισμου
CY1116344T1 (el) Κυτταρα προερχομενα απο ιστο ομφαλιου λωρου για την θεραπεια νευροπαθητικου πονου και σπαστικοτητας
CU23734A1 (es) Polipéptidos inmunomoduladores derivados de la il-2 con actividad antagonista de esta citocina útiles en la terapia del cáncer y enfermedades infecciosas crónicas
BR112014026090A2 (pt) composição de matriz tecidual apta a fluir, estojo, método de fabricação de uma composição de matriz tecidual apta a fluir, método de tratamento, e uso da composição de matriz tecidual apta a fluir
BR112019017393A8 (pt) Composição farmacêutica de evolocumab e seu uso, kit, método para preparar polipeptídeo de ligação a pcsk9 e método para formular polipeptídeo terapêutico
BR112017027985A2 (pt) peptídeos terapêuticos e métodos de uso dos mesmos
BR112022001415A2 (pt) Agentes interleucina-2 e os usos dos mesmos
BR112022003335A2 (pt) Conjugados de il-2 e métodos de uso para tratar doenças autoimunes
BR112012013329A2 (pt) composição oral e método para o tratamento de uma doença ou condição do tecido mole da cavidade oral
BR112017016087A2 (pt) formulações para coxim articular adiposo e métodos de uso das mesmas
BR112019004254A2 (pt) inibidores da dopamina-b-hidroxilase penetrantes da barreira hematoencefálica
BR112022004397A2 (pt) Composições para tratamento bucal que compreendem beta ácidos de lúpulo e aminoácidos
BR112021015751A2 (pt) Vetores de terapia genética para tratamento da doença de danon
BR112017009267A2 (pt) métodos e composições para preservar a massa corporal magra e promover a perda de gordura durante a perda de peso
CL2021000129A1 (es) Apirasas solubilizadas, métodos y usos
BR112017027897A2 (pt) usos terapêuticos das formulações de berberina
CO2023000114A2 (es) Composiciones y métodos para el tratamiento de enfermedades y trastornos usando vesículas extracelulares microbianas de oscillospiraceae
CO2023001509A2 (es) Cepa c de prevotella histicola como terapia oral para enfermedades inflamatorias
BR112021019109A2 (pt) Célula rpe manipulada, composições, molécula isolada de dna de fita dupla, dispositivo implantável, cápsula de hidrogel, e, método para aplicar uma terapia com fvii
BR112021009616A8 (pt) Composição cicatrizante que compreende água eletrolisada e máscara de aplicação cutânea
BR112023004271A2 (pt) Composições de ativação de sting polivalentes e usos das mesmas